Comparing the efficacy and safety of the combination of minoxidil 2.5 mg dutasteride 0.5 mg with minoxidil 2.5 mg and dutasteride 0.5 mg alone in the treatment of androgenic alopecia in me
- Conditions
- Androgenic Alopecia.Androgenic alopecia
- Registration Number
- IRCT20240304061159N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 45
Patients aged 18 to 60 years with male androgenetic alopecia grade 2 to 4 vertex of Norwood-Hamilton classification who have not received any other medical treatment for hair loss in the last 6 months
Patients who are not diagnosed with androgenic alopecia or are being treated with other drugs, and patients with grade I of androgenic alopecia and patients with severe complications after taking drugs are excluded from the study. Liver and TSH tests (tests in the last 6 months can be it is accepted) it is requested that they will be excluded from the study in case of disorder. Patients with a history of hair transplantation and patients with prostate and breast cancer in the last 5 years will be excluded from the study. patients with a history of diseases related to the right ventricle and neurogenic hypotension And spinal injuries are not included in the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method